Academia is a powerful source of innovation, generating novel solutions to both longstanding and emerging medical challenges. UMCs offer a wealth of clinical experience and deep matter expertise to identify new drug opportunities. But turning an opportunity into a product is a challenge. 

Turning a discovery into a treatment requires more than a strong research foundation. It also involves regulatory strategy, clinical development, funding, partnerships, manufacturing, market access, and a viable route to sustainable patient access. That long and challenging road is exactly where many projects fail.   

This session is designed to help you navigate that road. 

You can find more about the event and to register here.